The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China - 05 Feb `25Stem-cell exosome nasal drops for vitiligo

Stem-cell exosome nasal drops for vitiligo

Official title: Exploratory Clinical Study on Induced Pluripotent Stem Cell Derived Exosomes (iPSC-Exos) for the Treatment of Stable Vitiligo

Status: Opening soon

Description:

Second Affiliated Hospital of Wannan Medical College plans to enroll about 29 participants. This experimental treatment uses cell-derived particles and signaling proteins intended to change inflammation and tissue repair. Researchers hope these signals will protect melanocytes and encourage pigment to return. Possible risks include injection or infusion reactions, allergy, inflammation, infection, and other effects that are not yet known. People ages 18 to 60 may qualify. Recruitment has not started yet; the record lists one listed site in China.

Start date: February 05, 2025

Completion date: November 17, 2026

Organizer: Second Affiliated Hospital of Wannan Medical College

Contact: Ruzhi Zhang, MD; PhD

Tel.: 055 328 631 72

Email: 18755377606@163.com

Link: https://clinicaltrials.gov/study/NCT06810869

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Stem-cell exosome nasal drops for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions